NVIDIA
NVDA
Tesla
TSLA
Super Micro Computer
SMCI
4
Palantir
PLTR
5
Hims & Hers Health
HIMS
US Stock MarketDetailed Quotes
OTLK Outlook Therapeutics
- 1.480
- -0.040-2.63%
Close Feb 25 16:00 ET
- 1.630
- +0.150+10.14%
Post 20:01 ET
47.39MMarket Cap-0.60P/E (TTM)
1.540High1.441Low412.07KVolume1.540Open1.520Pre Close612.30KTurnover1.75%Turnover RatioLossP/E (Static)32.02MShares12.85052wk High-0.94P/B34.92MFloat Cap0.87052wk Low--Dividend TTM23.60MShs Float219.200Historical High--Div YieldTTM6.55%Amplitude0.870Historical Low1.485Avg Price1Lot Size
Outlook Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q1)Dec 31, 2024 | (FY)Sep 30, 2024 | (Q4)Sep 30, 2024 | (Q3)Jun 30, 2024 | (Q2)Mar 31, 2024 | (Q1)Dec 31, 2023 | (FY)Sep 30, 2023 | (Q4)Sep 30, 2023 | (Q3)Jun 30, 2023 | (Q2)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | 109.31%21.61M | 34.97%71.7M | 83.62%22.88M | 7.83%19.56M | 176.98%18.94M | -34.20%10.32M | -15.77%53.13M | -10.93%12.46M | 6.56%18.14M | -63.84%6.84M |
| Selling and administrative expenses | 106.20%11.95M | 12.25%29.94M | 37.78%10.35M | 18.76%8.36M | -13.70%5.43M | -0.55%5.79M | 28.61%26.67M | 50.36%7.51M | 21.91%7.04M | -5.93%6.29M |
| -General and administrative expense | 106.20%11.95M | 12.25%29.94M | 37.78%10.35M | 18.76%8.36M | -13.70%5.43M | -0.55%5.79M | 28.61%26.67M | 50.36%7.51M | 21.91%7.04M | -5.93%6.29M |
| Research and development costs | 113.28%9.66M | 57.88%41.76M | 153.29%12.52M | 0.90%11.2M | 2,378.94%13.51M | -54.07%4.53M | -37.51%26.45M | -45.00%4.94M | -1.31%11.1M | -95.54%544.95K |
| Operating profit | -109.31%-21.61M | -34.97%-71.7M | -83.62%-22.88M | -7.83%-19.56M | -176.98%-18.94M | 34.20%-10.32M | 15.77%-53.13M | 10.93%-12.46M | -6.56%-18.14M | 63.84%-6.84M |
| Net non-operating interest income expense | -74.09%48.88K | -44.31%-2.25M | -21.54%239.95K | 2.37%404.59K | -1,742.24%-3.08M | 107.71%188.68K | -4.86%-1.56M | 184.80%305.82K | 210.73%395.23K | 144.89%187.79K |
| Non-operating interest income | -74.09%48.88K | -6.72%906.15K | -21.59%239.95K | 2.29%404.59K | ---- | --188.68K | --971.48K | --306.02K | --395.54K | ---- |
| Non-operating interest expense | ---- | 24.72%3.16M | --0 | --0 | ---- | ---- | 70.17%2.53M | --206 | --303 | ---- |
| Total other finance cost | ---- | ---- | ---- | ---- | 1,742.24%3.08M | ---- | ---- | ---- | ---- | -144.89%-187.79K |
| Other net income (expense) | 3,830.20%38.94M | 67.16%-1.41M | 3,482.31%28.33M | 2,270.32%63.57M | -6,834,132.07%-92.26M | -98.48%-1.04M | -187.93%-4.29M | -21,277.17%-837.56K | -1,741.47%-2.93M | 99.64%-1.35K |
| Gain on sale of security | 75,599.38%40.27M | 2,154.62%1.15M | 209,078.42%28.85M | 477,262.12%56.06M | -449,803.92%-83.71M | -276.28%-53.34K | -89.07%50.92K | 23.36%13.79K | -105.11%-11.75K | 174.42%18.62K |
| Earnings from equity interest | -1,406.71%-33.3K | -816.00%-100.74K | -82.01%-15.2K | -699.90%-57.5K | -80.34%-30.6K | -88.15%2.55K | 77.43%-11K | -15.55%-8.35K | 39.11%-7.19K | -180.69%-16.97K |
| Special income (charges) | ---- | --0 | --0 | --0 | --0 | ---- | 43.67%-577.66K | --0 | --0 | --0 |
| -Less:Other special charges | ---- | ---- | ---- | ---- | ---- | ---- | -43.67%577.66K | --0 | ---- | ---- |
| Other non- operating income (expenses) | -31.32%-1.3M | 34.58%-2.46M | 39.74%-508K | 359.90%7.56M | -283,871.77%-8.52M | ---993K | -325.41%-3.76M | ---843K | -671.96%-2.91M | 99.13%-3K |
| Income before tax | 255.46%17.38M | -27.78%-75.36M | 143.81%5.69M | 314.80%44.41M | -1,618.20%-114.29M | 40.10%-11.18M | 10.70%-58.98M | 9.44%-12.99M | -17.87%-20.68M | 66.24%-6.65M |
| Income tax | 0.00%2.8K | 0 | 0 | 0.00%2.8K | 0.00%2.8K | 0 | 0 | 40.00%2.8K | ||
| Net income | 255.46%17.38M | -27.78%-75.37M | 143.81%5.69M | 314.80%44.41M | -1,617.52%-114.29M | 40.10%-11.18M | 10.70%-58.98M | 9.44%-12.99M | -17.87%-20.68M | 66.23%-6.65M |
| Net income continuous Operations | 255.46%17.38M | -27.78%-75.37M | 143.81%5.69M | 314.80%44.41M | -1,617.52%-114.29M | 40.10%-11.18M | 10.70%-58.98M | 9.44%-12.99M | -17.87%-20.68M | 66.23%-6.65M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 255.46%17.38M | -27.78%-75.37M | 143.81%5.69M | 314.80%44.41M | -1,617.52%-114.29M | 40.10%-11.18M | 10.70%-58.98M | 9.44%-12.99M | -17.87%-20.68M | 66.23%-6.65M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | 66.96M | 0 | ||||||||
| Net income attributable to common stockholders | 255.46%17.38M | -27.78%-75.37M | 143.81%5.69M | -9.05%-22.55M | -1,617.52%-114.29M | 40.10%-11.18M | 10.70%-58.98M | 9.44%-12.99M | -17.87%-20.68M | 66.23%-6.65M |
| Basic earnings per share | 183.72%0.72 | 13.98%-4.06 | 176.77%0.76 | 218.63%1.91 | -1,440.38%-8.01 | 46.25%-0.86 | 23.87%-4.72 | 17.50%-0.99 | -0.63%-1.61 | 71.11%-0.52 |
| Diluted earnings per share | 183.72%0.72 | 13.98%-4.06 | 176.77%0.76 | 44.72%-0.89 | -1,440.38%-8.01 | 46.25%-0.86 | 23.87%-4.72 | 17.50%-0.99 | -0.63%-1.61 | 71.11%-0.52 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- |